Cell Reports (Aug 2023)

IL-2 can signal via chemokine receptors to promote regulatory T cells’ suppressive function

  • Hao Sun,
  • Ho-Sup Lee,
  • Sarah Hyun-Ji Kim,
  • Mikhael Fernandes de Lima,
  • Alexandre R. Gingras,
  • Qinyi Du,
  • Wilma McLaughlin,
  • Jailail Ablack,
  • Miguel A. Lopez-Ramirez,
  • Frederic Lagarrigue,
  • Zhichao Fan,
  • John T. Chang,
  • Derek VanDyke,
  • Jamie B. Spangler,
  • Mark H. Ginsberg

Journal volume & issue
Vol. 42, no. 8
p. 112996

Abstract

Read online

Summary: Canonical interleukin-2 (IL-2) signaling via the high-affinity CD25-containing IL-2 receptor-Janus kinase (JAK)1,3-signal transducer and activator of transcription 5 (STAT5) pathway is essential for development and maintenance of CD4+CD25HiFoxp3+ regulatory T cells (Tregs) that support immune homeostasis. Here, we report that IL-2 signaling via an alternative CD25-chemokine receptor pathway promotes the suppressive function of Tregs. Using an antibody against CD25 that biases IL-2 signaling toward this alternative pathway, we establish that this pathway increases the suppressive activity of Tregs and ameliorates murine experimental autoimmune encephalomyelitis (EAE). Furthermore, heparan sulfate, an IL-2-binding element of cell surfaces and extracellular matrix, or an engineered IL-2 immunocytokine can also direct IL-2 signaling toward this alternative pathway. Overall, these data reveal a non-canonical mechanism for IL-2 signaling that promotes suppressive functions of Tregs, further elucidates how IL-2 supports immune homeostasis, and suggests approaches to promote or suppress Treg functions.

Keywords